Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 209,920,998 papers from all fields of science
Search
Sign In
Create Free Account
Bordetella pertussis Adenylate Cyclase Toxin
Known as:
Pertussis Adenylate Cyclase-Haemolysin Bifunctional Protein
, Adenylate Cyclase-Haemolysin Bifunctional Protein, B. pertussis
, Adenylate Cyclase Haemolysin Bifunctional Protein, B. pertussis
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Adenylate Cyclase Toxin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
BU10038 as a safe opioid analgesic with fewer side-effects after systemic and intrathecal administration in primates.
N. Kiguchi
,
H. Ding
,
+7 authors
M. Ko
British Journal of Anaesthesia
2019
Corpus ID: 59593031
2019
2019
Dual Pharmacophores Explored via Structure-Activity Relationship (SAR) Matrix: Insights into Potent, Bifunctional Opioid Ligand Design.
Anthony F. Nastase
,
Jessica P. Anand
,
+6 authors
H. Mosberg
Journal of Medicinal Chemistry
2019
Corpus ID: 85543763
Short-acting μ-opioid receptor (MOR) agonists have long been used for the treatment of severe, breakthrough pain. However…
Expand
2016
2016
HpDTC1, a Stress-Inducible Bifunctional Diterpene Cyclase Involved in Momilactone Biosynthesis, Functions in Chemical Defence in the Moss Hypnum plumaeforme
K. Okada
,
H. Kawaide
,
+11 authors
Ken-ichiro Hayashi
Scientific Reports
2016
Corpus ID: 24796068
Momilactones, which are diterpenoid phytoalexins with antimicrobial and allelopathic functions, have been found only in rice and…
Expand
2014
2014
Human full-length coagulation factor X and a GLA domain-derived 40-mer polypeptide bind to different regions of the adenovirus serotype 5 hexon capsomer.
Sudir Sumarheni
,
Saw-See Hong
,
+4 authors
P. Fender
Human Gene Therapy
2014
Corpus ID: 12636518
The interaction of human adenovirus (HAdV)-C5 and many other adenoviruses with blood coagulation factors (e.g., human factor X…
Expand
Highly Cited
2009
Highly Cited
2009
Comparison of the Antinociceptive and Antirewarding Profiles of Novel Bifunctional Nociceptin Receptor/μ-Opioid Receptor Ligands: Implications for Therapeutic Applications
L. Toll
,
T. Khroyan
,
W. Polgar
,
F. Jiang
,
C. Olsen
,
N. Zaveri
Journal of Pharmacology and Experimental…
2009
Corpus ID: 22847157
The nociceptin receptor (NOPr), a member of the opioid receptor family, is a target for the treatment of pain and drug abuse…
Expand
Highly Cited
1997
Highly Cited
1997
Evidence for genetic linkage between the ure and trh genes in Vibrio parahaemolyticus.
T. Iida
,
O. Suthienkul
,
+5 authors
T. Honda
Journal of Medical Microbiology
1997
Corpus ID: 11934301
Although V. parahaemolyticus does not generally produce urease, several studies have reported urease-positive V. parahaemolyticus…
Expand
1996
1996
Nature of the cation leak induced in erythrocyte membranes by Kanagawa haemolysin of Vibrio parahaemolyticus.
J. Huntley
,
A. Hall
Biochimica et Biophysica Acta
1996
Corpus ID: 37650405
1981
1981
Stabilization of vasopressin-induced membrane events by bifunctional imidoesters
J. Rapoport
,
W. Kachadorian
,
J. Muller
,
N. Franki
,
R. M. Hays
Journal of Cell Biology
1981
Corpus ID: 11776833
Vasopressin increases the water permeability of the luminal membrane of the toad bladder epithelial cell. This change in…
Expand
1957
1957
Research into biochemical factors of inflammation; necrosin (macrocytase) and haemolysin of inflammatory exudates.
V. Gorkin
Clinica chimica acta; international journal of…
1957
Corpus ID: 37026547
1951
1951
The haemolysin of Bacterium coli.
G. L. Robinson
Journal of General Microbiology
1951
Corpus ID: 35649379
SUMMARY: Conditions for haemolysis by Bacterium coli have been investigated. The haemolytic factor is specific to haemolytic…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE